首页|补肾益气活血法对原发性肾病综合征患者肝功、肾功、尿蛋白等指标的影响研究

补肾益气活血法对原发性肾病综合征患者肝功、肾功、尿蛋白等指标的影响研究

扫码查看
目的:研究补肾益气益气法治疗原发性肾病综合征的临床疗效.方法:选择本院自2021年1月~2022年1月收治的80名原发性肾脏疾病患者,采用随机数表法,分成2组,观察组40例患者联合补肾益气活血法治疗,对比患者临床疗效、肝功、肾功、尿蛋白等指标水平.结果:试验组临床疗效及AST、ALB、BUN均较对照组升高(P<005),血清ALT、Scr及24小时尿蛋白含量及总胆固醇较对照组降低(P<005);观察组不良反应率低于对照组(P<0.05).结论:PNS患者以补肾益气活血法治疗,临床疗效较为理想,可在一定程度上改善肝功、肾功及尿蛋白等指标水平,减少不良反应,该具有较高应用价值.
Study on the effect of tonifying the kidney,promoting qi and activating blood on liver function,kidney function,u-rine protein and other indexes of patients with primary nephrotic syndrome(PNS)
Objective:To investigate the effects of invigorating kidney and invigorating Qi on liver function,kidney function and urinary protein in patients with primary nephrotic syndrome(PNS).Methods:80patients with primary nephrotic syndrome treated in our hospital from January 2021to January 2022were divided into two groups by random number table method.40patients in the control group received conventional treatment,and 40patients in the observation group received combined treatment with in-vigorating kidney for qi and promoting blood circulation.Clinical efficacy,liver function,kidney function,urinary protein and other indexes of patients were compared.Results:The clinical efficacy,AST,ALB and BUN of observation group were higher than those of control group(P<0.05),ALT,Scr,24h urinary protein quantity and TC level were lower than those of control group(P<0.05).The adverse reaction rate of observation group was lower than that of control group(P<0.05).Conclusion:The therapeutic effect of tonifying kidney and invigorating qi and activating blood in PNS patients is ideal,which can improve liver function,kidney function and urinary protein levels to a certain extent and reduce adverse reactions,which has high application value.

tonifying the kidney invigorating qi and activating bloodprimary nephrotic syndromeliver functionkidney functionurinary proteineffect

郑阔、张坤、孙永贺

展开 >

太和县中医院肾病科,安徽太和 236600

补肾益气活血法 原发性肾病综合征 肝功 肾功 尿蛋白 影响

2024

四川中医
四川省中医药学会,四川省中西医结合学会,四川省针灸学会,四川省中医药科学院

四川中医

CSTPCD
影响因子:0.522
ISSN:1000-3649
年,卷(期):2024.42(5)
  • 18